Regulation of translation initiation by the epitranscriptome
Active Project Grant Awarded Last action
- Award ID
- R35GM159598
- Recipient
-
Northwestern University UEI KG76WYENL5K1
- Awarding agency
-
National Institute of General Medical Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $880,000
Award facts
- Assistance listing
- 93.859 Biomedical Research and Research Training
- Completion date 26% complete
- Place of performance
- Chicago, IL 60611, USA
Award details come from USAspending.gov.
Description
- Abstract
- My research program investigates how the epitranscriptome regulates protein synthesis and how this interplay affects cell fate decisions under normal homeostasis and stress conditions. The epitranscriptome is the collection of more than 150 chemical modifications that occur on RNA molecules and influence all steps of gene expression. One such step is the translation of mrnas - the process by which the information stored in DNA is converted into functional proteins. Though translation typically initiates at an optimal 'AUG' start codon, the 5' untranslated region (5'UTR) can harbor cryptic initiation sites. These cryptic sites result in upstream open reading frames (uorfs) that generally regulate the expression of canonical proteins but can also produce new minipeptides with diverse biological functions. Importantly, these uorfs are not merely errors in translation but serve as regulatory mechanisms typically CO-opted by cells when exposed to stress conditions. Hence, understanding how cells harness the noncanonical mechanisms of translation to their advantage remains a fundamental question in biology. My published and preliminary studies demonstrate that different RNA modifications and their cognate RNA- modifying enzyme dynamically regulate translation initiation. Under this mira award, my research program will integrate RNA biochemistry, chemical biology, transcriptomics, and cell biology to fill gaps in our understanding of how RNA modifications regulate uorf expression and the adaptability of eukaryotic cells to stress conditions. We will also investigate how genetic and physical interactions between RNA-modifying enzymes and translation factors influence the noncanonical mechanism of translation initiation. Lastly, we will implement synthetic biology strategies to modulate the expression of aberrant uorfs in transcript-specific manners. Overall, this research program will provide new insights on how the epitranscriptome is harnessed to diversify the coding potential of the genome. Our long-term goal is to pioneer conceptual leaps and technological innovations to comprehend and manipulate the epitranscriptome for the benefit of human health.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $440,000 | |
| Original award | $440,000 |
Quick answers
Who received award R35GM159598?
R35GM159598 was awarded to Northwestern University by National Institute of General Medical Sciences (National Institutes of Health) on August 1, 2025.
How much is award R35GM159598 worth?
$880,000 has been obligated on R35GM159598.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award